MYNDFMYND Life Sciences Inc.

About MYND Life Sciences Inc. (MYNDF)

MYND Life Sciences Inc. (MYNDF) is a Biotechnology company headquartered in Port Coquitlam, BC, Canada whose shares trade over-the-counter on the Pink tier.

Mynd is a life sciences based neuro-pharmaceutical drug development company advancing medicines that leverage psychedelic compounds. Our mission is to further our existing research and patents linking depression and inflammation at the genetic and cellular level to develop pharmaceutical treatments.

Products and services

Mynd is a neropharmalogig drug discovery with a focus on utilizing psilobin and its analogs for cns inflamatorry disese inclusding depresstion, Alzhaimers, MS and others.

MYNDF key facts

Ticker symbol

MYNDF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Port Coquitlam, BC, Canada

Country of incorporation

CA

Year of incorporation

2020

Employees

6

Estimated market cap

$745.5K (as of May 13, 2025)

Shares outstanding

74,547,806

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

10/31

Latest filing

Interim Financial Report (Jul 31, 2024)

MYND Life Sciences Inc. leadership

• Colin Campbell — CEO
• Lih-Ming Tam — CFO
• Wilfred Jefferies — CSO
• Suzanne M Ferguson — Other

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with M